About this trial
This research will use biobehavioral approaches to generate understanding about the linkages between sleep duration and timing, stressful life events, and depressive symptoms in adolescents, with a long-term aim of developing effective preventative interventions.
Eligibility criteria
Qualifiers
14-18 years of age
Currently in high school
short and late sleep (weekday sleep duration ≤ 7 h and bedtime ≥ 22:30 (10:30 pm); n=100) or long and early sleep (weekday sleep duration > 7 hours and bedtime ≤ 22:30 (10:30 pm); n=50), indexed by the Munich Chronotype Questionnaire
Lifetime stressful event frequency ≥ 2 on the Stress and Adversity Inventory (STRAIN) Screener
Disqualifiers
Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) criteria for current moderate to severe alcohol/substance use disorder (≥4 symptoms);
Current clinician-provided diagnosis of narcolepsy or idiopathic hypersomnia;
Lifetime diagnosis of bipolar or schizophrenia spectrum disorder;
Certain medical conditions (e.g., serious neurological disorder, heart failure or serious heart trouble, history of head injury with unconsciousness > 5 minutes);
Trial design
Treatments tested in this trial
- Sleep extension and advance
- Regular sleep duration and timing
Treatment groups
Locations
1Sponsors and collaborators
University of Oregon
Lead sponsor
Oregon Research Institute
Collaborator
University of Pittsburgh
Collaborator
National Institute of Mental Health (NIMH)
Collaborator